Telik Inc (NASDAQ:TELK)

CAPS Rating: 2 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Recs

0
Player Avatar Moska (< 20) Submitted: 2/18/2007 8:32:47 PM : Outperform Start Price: $169.80 TELK Score: -93.25

Despite its failure in the drug tests, it has been way oversold and still has potential to bring in other drugs.

Report this Post Reply

Featured Broker Partners


Advertisement